Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer-Reference-Cited by-同舟云学术

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer

Published:2007-05-24 Issue:4 Volume:61 Page:623-629
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Park Yeon Hee,Lee Jae-Lyun,Ryoo Baek-Yeol,Ryu Min-Hee,Yang Sung Hyun,Kim Bong Seog,Shin Dong Bok,Chang Heung Moon,Kim Tae Won,Yuh Young Jin,Kang Yoon-Koo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0515-7.pdf

Reference29 articles.

1. Parkin DM, Pisani P, Perlay J (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

2. National Statistical Office (2001) Annual report on the cause of death statistics in Korea, pp 7–15

3. Hong YS, Song SY, Lee SI, Chung HC, Choi SH, Noh SH, Park JN, Han JY, Kang JH, Lee KS, Cho JY (2004) A phase II trial of capecitabine in chemotherapy naïve patients with advanced and/or metastatic gastric cancer. Ann Oncol 15:1344–1347

4. Park YH, Ryoo BR, Choi SJ, Kim HT (2004) A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer. Br J Cancer 90:1329–1333

5. Thuss-Patience PC, Kretzschmar A, Repp M, Kingreen D, Hennesser D, Micheel S, Pink D, Scholz C, Dorken B, Reichardt P (2005) Docetaxel and continuous-infusion fluorouracil vs epirubicin, cisplatin and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study. J Clin Oncol 23:494–501

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis;Computer Methods and Programs in Biomedicine Update;2024

2. Efficacy and safety of PD-1/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis;Frontiers in Oncology;2023-04-11

3. A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation;Journal of Gastric Cancer;2023

4. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies;Nature Communications;2022-09-29

5. Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study;Cancer Management and Research;2022-03